Liver Disease
Conference Coverage
Type 2 diabetes remission: Reducing excess fat in the liver might be the key
LOS ANGELES – ...
From the Journals
Survey: Palliative care blocked by many barriers in end-stage liver disease
Formal palliative care training was lacking among the physicians surveyed.
Conference Coverage
Ribavirin boosts HCV genotype 3 eradication in compensated cirrhotic patients
VIENNA – Data from more than 14,000 English patients showed incremental benefit from ribavirin when treating hepatitis C genotype 3 virus.
From the Journals
Tailoring the Mediterranean diet for NAFLD
Keys to success included providing recipes and meal planners, education on how lifestyle and diet contribute to NAFLD, and offering care in person...
Conference Coverage
Fecal microbiota transplant shows promise for hepatic encephalopathy
VIENNA – Fecal microbiota transplant was safe and suggested efficacy for hepatic encephalopathy patients in a phase 1 study.
Conference Coverage
VIDEO: Givosiran cuts acute intermittent porphyria attacks in pivotal trial
Despite a modest number of severe adverse effects givosiran seems headed to be the first FDA-approved agent for acute hepatic porphyria.
Conference Coverage
Tenofovir disoproxil treated HBV with fewer future HCCs
VIENNA - Chronic hepatitis B virus-infected patients treated with tenofovir disoproxil fumarate developed significantly fewer hepatocellular...
Conference Coverage
Three-drug regimen shows promise for refractory primary biliary cholangitis
VIENNA – Combining ursodeoxycholic acid, obeticholic acid, and bezafibrate showed efficacy and tolerability for the toughest cases.
From the Journals
HCC linked to mitochondrial damage, iron accumulation from HCV
Mitochondrial damage and iron accumulation from HCV are linked to the development of hepatocellular carcinoma.
Conference Coverage
Blunted cardiac reserve strongly predicts incident hepatorenal syndrome
VIENNA – Cirrhotic patients with end-stage liver disease and a blunted cardiac response to dobutamine had a high...